These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27941393)

  • 21. Anti-inflammatory effects of atorvastatin treatment in chronic obstructive pulmonary disease. A controlled pilot study.
    Mroz RM; Lisowski P; Tycinska A; Bierla J; Trzeciak PZ; Minarowski L; Milewski R; Lisowska A; Boros P; Sobkowicz B; Duszewska AM; Chyczewska E; Musial WJ; MacNee W
    J Physiol Pharmacol; 2015 Feb; 66(1):111-28. PubMed ID: 25716971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel relationships of markers of monocyte activation and endothelial dysfunction with pulmonary dysfunction in HIV-infected persons.
    Fitzpatrick ME; Nouraie M; Gingo MR; Camp D; Kessinger CJ; Sincebaugh JB; Clarke A; Ries JW; Kleerup EC; Kingsley L; Morris A
    AIDS; 2016 Jun; 30(9):1327-39. PubMed ID: 26990629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significant chronic airway abnormalities in never-smoking HIV-infected patients.
    Besutti G; Santoro A; Scaglioni R; Neri S; Zona S; Malagoli A; Orlando G; Beghè B; Ligabue G; Torricelli P; Manfredini M; Pellacani G; Fabbri LM; Guaraldi G
    HIV Med; 2019 Nov; 20(10):657-667. PubMed ID: 31577384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials.
    Franciosi LG; Diamant Z; Banner KH; Zuiker R; Morelli N; Kamerling IM; de Kam ML; Burggraaf J; Cohen AF; Cazzola M; Calzetta L; Singh D; Spina D; Walker MJ; Page CP
    Lancet Respir Med; 2013 Nov; 1(9):714-27. PubMed ID: 24429275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvements in Lung Diffusion Capacity following Pulmonary Rehabilitation in COPD with and without Ventilation Inhomogeneity.
    Santus P; Radovanovic D; Balzano G; Pecchiari M; Raccanelli R; Sarno N; Di Marco F; Jones PW; Carone M
    Respiration; 2016; 92(5):295-307. PubMed ID: 27598467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adiposity influences airway wall thickness and the asthma phenotype of HIV-associated obstructive lung disease: a cross-sectional study.
    Barton JH; Ireland A; Fitzpatrick M; Kessinger C; Camp D; Weinman R; McMahon D; Leader JK; Holguin F; Wenzel SE; Morris A; Gingo MR
    BMC Pulm Med; 2016 Aug; 16(1):111. PubMed ID: 27488495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
    Broseghini C; Testi R; Polese G; Tosatto R; Rossi A
    Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determine the effectiveness of lipid-lowering therapy in patients with chronic obstructive pulmonary disease combined with coronary heart disease.
    Zhdan V; Khaymenova G; Shilkina L; Martynyuk D; Babanina M; Mamontova T
    Wiad Lek; 2017; 70(2 pt 2):303-305. PubMed ID: 29059648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
    Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Spirometry and other pulmonary function tests for the screening and evaluation of patients with chronic obstructive pulmonary disease (COPD)].
    Yoshimi K; Seyama K
    Nihon Rinsho; 2007 Apr; 65(4):664-9. PubMed ID: 17419385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study.
    Bateman ED; van Dyk M; Sagriotis A
    Pulm Pharmacol Ther; 2008; 21(1):20-5. PubMed ID: 17118684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD.
    Bhatt SP; Dransfield MT; Cockcroft JR; Wang-Jairaj J; Midwinter DA; Rubin DB; Scott-Wilson CA; Crim C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():351-365. PubMed ID: 28176907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of periodontal treatment on lung function and exacerbation frequency in patients with chronic obstructive pulmonary disease and chronic periodontitis: a 2-year pilot randomized controlled trial.
    Zhou X; Han J; Liu Z; Song Y; Wang Z; Sun Z
    J Clin Periodontol; 2014 Jun; 41(6):564-72. PubMed ID: 24593836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic Obstructive Pulmonary Disease: Pulmonary Function and CT Lung Attenuation Do Not Show Linear Correlation.
    Paoletti M; Cestelli L; Bigazzi F; Camiciottoli G; Pistolesi M
    Radiology; 2015 Aug; 276(2):571-8. PubMed ID: 25848902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimum clinically important difference in diffusing capacity of the lungs for carbon monoxide among patients with severe and very severe chronic obstructive pulmonary disease.
    Horita N; Miyazawa N; Kojima R; Inoue M; Ishigatsubo Y; Kaneko T
    COPD; 2015 Feb; 12(1):31-7. PubMed ID: 24915470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities].
    Beeh KM; Beier J; Buhl R; Stark-Lorenzen P; Gerken F; Metzdorf N;
    Pneumologie; 2006 Jun; 60(6):341-6. PubMed ID: 16761228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial.
    Vitulo P; Stanziola A; Confalonieri M; Libertucci D; Oggionni T; Rottoli P; Paciocco G; Tuzzolino F; Martino L; Beretta M; Callari A; Amaducci A; Badagliacca R; Poscia R; Meloni F; Refini RM; Geri P; Baldi S; Ghio S; D'Alto M; Argiento P; Sofia M; Guardamagna M; Pezzuto B; Vizza CD
    J Heart Lung Transplant; 2017 Feb; 36(2):166-174. PubMed ID: 27329400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease.
    Rennard SI; Dale DC; Donohue JF; Kanniess F; Magnussen H; Sutherland ER; Watz H; Lu S; Stryszak P; Rosenberg E; Staudinger H
    Am J Respir Crit Care Med; 2015 May; 191(9):1001-11. PubMed ID: 25695403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Transcutaneous Electrical Acupoint Stimulation on Patients with Stable Chronic Obstructive Pulmonary Disease: A Prospective, Single-Blind, Randomized, Placebo-Controlled Study.
    Liu X; Fan T; Lan Y; Dong S; Fu J; Mao B
    J Altern Complement Med; 2015 Oct; 21(10):610-6. PubMed ID: 26218785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffusion capacity of the lung for carbon monoxide - A potential marker of impaired gas exchange or of systemic deconditioning in chronic obstructive lung disease?
    Weinreich UM; Thomsen LP; Brock C; Karbing DS; Rees SE
    Chron Respir Dis; 2015 Nov; 12(4):357-64. PubMed ID: 26323278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.